OTC Healthcare in Portugal

Published by: Euromonitor International

Published: Apr. 1, 2009

Table of Contents

OTC HEALTHCARE IN PORTUGAL : MARKET INSIGHT

EXECUTIVE SUMMARY

OTC healthcare achieves continued positive retail value growth in 2008

Ageing population and self-medication boost demand for OTC healthcare

Trend of self-medication benefits popular brands

Increased distribution promotes growth of OTC healthcare

Constant value growth of OTC healthcare to remain positive

KEY TRENDS AND DEVELOPMENTS

Economic crisis hampers growth of some categories of OTC healthcare

Ageing population, a key driver of demand for products in OTC healthcare

Self-medication, an accelerator of growth of OTC healthcare

Smoking ban boosts demand for products in NRT smoking cessation aids

Competition between distribution channels positively impacts OTC healthcare

MARKET INDICATORS

Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008

Table 2 Life Expectancy at Birth 2003-2008

MARKET DATA

MARKET INDICATORS

Table 3 Consumer Expenditure on Health Goods and Medical Services 2003-2008

Table 4 Life Expectancy at Birth 2003-2008

MARKET DATA

Table 5 Sales of OTC Healthcare by Sector: Value 2003-2008

Table 6 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008

Table 7 OTC Healthcare Company Shares by Value 2004-2008

Table 8 OTC Healthcare Brand Shares by Value 2005-2008

Table 9 Penetration of Private Label by Sector 2003-2008

Table 10 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008

Table 11 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008

Table 12 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013

Table 13 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013

Table 14 Sales of OTC Healthcare by Sector: Value 2003-2008

Table 15 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008

Table 16 OTC Healthcare Company Shares by Value 2004-2008

Table 17 OTC Healthcare Brand Shares by Value 2005-2008

Table 18 Penetration of Private Label by Sector 2003-2008

Table 19 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008

Table 20 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008

Table 21 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013

Table 22 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013

APPENDIX

OTC Registration and Classification

EU Legislation

Self-medication and Preventative Medicine

Generics

Switches

DEFINITIONS

Summary 1 Research Sources

LOCAL COMPANY PROFILES - PORTUGAL

DERMOTECA-PRODUTOS QUIMICOS E DERMATOLOGICOS SA - OTC HEALTHCARE - PORTUGAL

STRATEGIC DIRECTION

KEY FACTS

Summary 2 Dermoteca-Produtos Quimicos e Dermatologicos SA: Key Facts

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 3 Dermoteca-Produtos Quimicos e Dermatologicos SA: Competitive Position 2008

GRUNENTHAL SA - OTC HEALTHCARE - PORTUGAL

STRATEGIC DIRECTION

KEY FACTS

Summary 4 Grunenthal SA: Key Facts

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 5 Laboratórios Andrómaco SA: Competitive Position 2008

LABORATORIO J NEVES, LDA - OTC HEALTHCARE - PORTUGAL

STRATEGIC DIRECTION

KEY FACTS

Summary 6 Laboratorio J Neves Lda: Key Facts

Summary 7 Laboratorio J Neves Lda: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 8 Laboratorio J Neves Lda: Competitive Position 2008

LABORATóRIO MEDINFAR PRODUTOS FARMACêUTICOS SA - OTC HEALTHCARE - PORTUGAL

STRATEGIC DIRECTION

KEY FACTS

Summary 9 Laboratório Medinfar Produtos Farmacêuticos SA: Key Facts

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 10 Laboratório Medinfar Produtos Farmacêuticos SA: Competitive Position 2008

NEO-FARMACêUTICA, LDA - OTC HEALTHCARE - PORTUGAL

STRATEGIC DIRECTION

KEY FACTS

Summary 11 Neo-Farmacêutica Lda: Key Facts

Summary 12 Neo-Farmaceutica Lda: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 13 Neo-Farmacêutica Lda: Competitive Position 2008

PEISFAR SA - OTC HEALTHCARE - PORTUGAL

STRATEGIC DIRECTION

KEY FACTS

Summary 14 Peisfar SA: Key Facts

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 15 Peisfar SA: Competitive Position 2008

ANALGESICS IN PORTUGAL

HEADLINES

TRENDS

SWITCHES

COMPETITIVE LANDSCAPE

PROSPECTS

SECTOR DATA

Table 23 Sales of Analgesics by Subsector: Value 2003-2008

Table 24 Sales of Analgesics by Subsector: % Value Growth 2003-2008

Table 25 Herbal vs Standard Topical Analgesics 2003-2008

Table 26 Topical Analgesics by Format: % Value Breakdown 2004-2008

Table 27 Analgesics Company Shares by Value 2004-2008

Table 28 Analgesics Brand Shares by Value 2005-2008

Table 29 Forecast Sales of Analgesics by Subsector: Value 2008-2013

Table 30 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013

COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN PORTUGAL

HEADLINES

TRENDS

COMPETITIVE LANDSCAPE

PROSPECTS

SECTOR DATA

Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008

Table 32 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008

Table 33 Sales of Decongestants by Type: Value 2003-2008

Table 34 Sales of Decongestants by Type: % Value Growth 2003-2008

Table 35 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008

Table 36 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008

Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008

Table 38 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013

Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013

DIGESTIVE REMEDIES IN PORTUGAL

HEADLINES

TRENDS

SWITCHES

COMPETITIVE LANDSCAPE

PROSPECTS

SECTOR DATA

Table 40 Sales of Digestive Remedies by Subsector: Value 2003-2008

Table 41 Sales of Digestive Remedies by Subsector: % Value Growth 2003-2008

Table 42 Herbal vs Standard Digestive Remedies 2003-2008

Table 43 Digestive Remedies Company Shares by Value 2004-2008

Table 44 Digestive Remedies Brand Shares by Value 2005-2008

Table 45 Forecast Sales of Digestive Remedies by Subsector: Value 2008-2013

Table 46 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2008-2013

MEDICATED SKIN CARE IN PORTUGAL

HEADLINES

TRENDS

SWITCHES

COMPETITIVE LANDSCAPE

PROSPECTS

SECTOR DATA

Table 47 Sales of Medicated Skin Care by Subsector: Value 2003-2008

Table 48 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008

Table 49 Herbal vs Standard Medicated Skin Care 2003-2008

Table 50 Acne Treatments by Format: % Value Breakdown 2004-2008

Table 51 Medicated Skin Care Company Shares by Value 2004-2008

Table 52 Medicated Skin Care Brand Shares by Value 2005-2008

Table 53 Acne Treatments Brand Shares by Value 2005-2008

Table 54 Hair Loss Treatments Brand Shares by Value 2005-2008

Table 55 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013

Table 56 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013

VITAMINS AND DIETARY SUPPLEMENTS IN PORTUGAL

HEADLINES

TRENDS - VITAMINS

TRENDS - DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

PROSPECTS

SECTOR DATA

Table 57 Dietary Supplements: Brand Ranking by Positioning 2008

SECTOR DATA

Table 58 Sales of Vitamins and Dietary Supplements by Subsector: Value 2003-2008

Table 59 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2003-2008

Table 60 Folic Acid v Other B Vitamins 2004-2008

Table 61 Dietary Supplements by Positioning 2006-2008

Table 62 Vitamins and Dietary Supplements Company Shares by Value 2004-2008

Table 63 Vitamins and Dietary Supplements Brand Shares by Value 2005-2008

Table 64 Vitamins Brand Shares by Value 2005-2008

Table 65 Dietary Supplements Brand Shares by Value 2005-2008

Table 66 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2008-2013

Table 67 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2008-2013

NRT SMOKING CESSATION AIDS IN PORTUGAL

HEADLINES

TRENDS

SWITCHES

COMPETITIVE LANDSCAPE

PROSPECTS

SECTOR INDICATORS

Table 68 Number of Smokers by Gender 2003-2008

SECTOR DATA

Table 69 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008

Table 70 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2003-2008

Table 71 NRT Gum Flavours: % Value Breakdown 2006-2008

Table 72 Smoking Cessation Aids Company Shares by Value 2004-2008

Table 73 Smoking Cessation Aids Brand Shares by Value 2005-2008

Table 74 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2008-2013

Table 75 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2008-2013

EYE CARE IN PORTUGAL

HEADLINES

SECTOR DATA

Table 76 Sales of Eye Care by Subsector: Value 2003-2008

Table 77 Sales of Eye Care by Subsector: % Value Growth 2003-2008

Table 78 Standard Eye Care by Type: % Value Breakdown 2007-2008

Table 79 Eye Care Company Shares by Value 2004-2008

Table 80 Eye Care Brand Shares by Value 2005-2008

Table 81 Forecast Sales of Eye Care by Subsector: Value 2008-2013

Table 82 Forecast Sales of Eye Care by Subsector: % Value Growth 2008-2013

EAR CARE IN PORTUGAL

HEADLINES

SECTOR DATA

Table 83 Sales of Ear Care: Value 2003-2008

Table 84 Sales of Ear Care: % Value Growth 2003-2008

Table 85 Ear Care Company Shares by Value 2004-2008

Table 86 Ear Care Brand Shares by Value 2005-2008

Table 87 Forecast Sales of Ear Care: Value 2008-2013

Table 88 Forecast Sales of Ear Care: % Value Growth 2008-2013

ADULT MOUTH CARE IN PORTUGAL

HEADLINES

SECTOR DATA

Table 89 Sales of Adult Mouth Care: Value 2003-2008

Table 90 Sales of Adult Mouth Care: % Value Growth 2003-2008

Table 91 Adult Mouth Care Company Shares by Value 2004-2008

Table 92 Adult Mouth Care Brand Shares by Value 2005-2008

Table 93 Forecast Sales of Adult Mouth Care: Value 2008-2013

Table 94 Forecast Sales of Adult Mouth Care: % Value Growth 2008-2013

CALMING AND SLEEPING PRODUCTS IN PORTUGAL

HEADLINES

SECTOR DATA

Table 95 Sales of Calming and Sleeping Products: Value 2003-2008

Table 96 Sales of Calming and Sleeping Products: % Value Growth 2003-2008

Table 97 Calming and Sleeping Products Company Shares by Value 2004-2008

Table 98 Calming and Sleeping Products Brand Shares by Value 2005-2008

Table 99 Forecast Sales of Calming and Sleeping Products: Value 2008-2013

Table 100 Forecast Sales of Calming and Sleeping Products: % Value Growth 2008-2013

WOUND TREATMENTS IN PORTUGAL

HEADLINES

SECTOR DATA

Table 101 Sales of Wound Treatments by Subsector: Value 2003-2008

Table 102 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008

Table 103 Wound Treatments Company Shares by Value 2004-2008

Table 104 Wound Treatments Brand Shares by Value 2005-2008

Table 105 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013

Table 106 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013

OTC OBESITY IN PORTUGAL

HEADLINES

SECTOR DATA

Table 107 Forecast Sales of OTC Obesity: Value 2009-2013

Table 108 Forecast Sales of OTC Obesity: % Value Growth 2009-2013

EMERGENCY CONTRACEPTION IN PORTUGAL

HEADLINES

SECTOR DATA

Table 109 Sales of Emergency Contraception: Value 2003-2008

Table 110 Sales of Emergency Contraception: % Value Growth 2003-2008

Table 111 Emergency Contraception Company Shares by Value 2004-2008

Table 112 Emergency Contraception Brand Shares by Value 2005-2008

Table 113 Forecast Sales of Emergency Contraception: Value 2008-2013

Table 114 Forecast Sales of Emergency Contraception: % Value Growth 2008-2013

Abstract

OTC healthcare achieves continued positive retail value growth in 2008

Despite the global economic slowdown, diminished consumer purchasing power and a slump in the morale of consumers OTC healthcare achieved continued positive retail value growth in 2008 as health and wellness remained a priority among the Portuguese. One of the factors from which OTC healthcare benefited was a ban on smoking in the workplace and in public spaces, which prompted many smokers to reduce their consumption of cigarettes. Analgesics also continued to drive retail value sales of OTC healthcare in 2008, as it remained the largest category in terms of retail value sales.

Ageing population and self-medication boost demand for OTC healthcare

Owing to the increasingly ageing Portuguese population, demand for OTC healthcare increased further in 2008. Ageing is a leading factor behind a wide range of diseases and as ageing consumers wish to live longer and age gracefully, demand for products in OTC healthcare has risen. There is strong demand for hair loss treatments, calming and sleeping products and also dietary supplements to prevent heart disease. On the other hand, consumers faced increasingly hectic lifestyles in 2008 and thus self-medication was a convenient alternative to having to spend time and money on visiting a doctor for minor ailments. Analgesics, in particular, has benefited from the trend of self-medication among consumers.

Trend of self-medication benefits popular brands

There are more than 100 companies operating in OTC healthcare in Portugal, some of which are domestic and the leaders of which are multinational players. Multinational players benefit from the preference among consumers for self-medication as this prompts them to opt for well-known brands, the results of which have been proven.

Increased distribution promotes growth of OTC healthcare

Following the liberalisation of the sale of medicinal products in OTC healthcare, the distribution landscape in OTC healthcare changed, as the focus was taken away from chemists/pharmacies. The number of distribution outlets for OTC healthcare increased and this helped to boost sales. In 2008, approximately 678 distribution outlets other than chemists/pharmacies outlets offered medicinal products in OTC healthcare. Nevertheless chemists/pharmacies remained the leading channel of distribution for OTC healthcare in 2008.

Constant value growth of OTC healthcare to remain positive

OTC healthcare is expected to continue to achieve positive constant value growth over the forecast period, driven by demand for NRT smoking cessation aids as more smokers in Portugal attempt to stop smoking and turn to products in OTC healthcare to help them. However, analgesics is expected to remain the largest category of OTC healthcare in terms of retail value sales over the forecast period, as the trend of self-medication is expected to increase further in Portugal and to continue to have a positive impact on OTC healthcare.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.